Thailand, Bulgaria delay jab launch; WHO, France, Germany support shot
The precautionary move follows signals of a possible serious side effect in the form of 'deadly blood clots'
The move comes after one person in Denmark who was given the AstraZeneca shot formed a blood clot and died, the Danish Health Authority said
AstraZeneca Pharma India on Wednesday said it has received marketing approval from the Drugs Controller General of India (DCGI)for its product for the treatment of non-small cell lung cancer.
Govt must consider tweaking the norms and pricing
Almost 21 million shots have been administered in India so far, up from 5.4 million a month ago
Last week, Adar Poonawalla had said on a World Bank panel that a US law blocking the export of key items like bags and filters will likely cause "serious bottlenecks" in vaccine production
The EU executive backed Italy's decision to block a shipment of 250,000 doses of the AstraZeneca vaccine to Australia, European officials said
The Standing Committee on Vaccination (STIKO) in Germany updated its reference and now recommended the COVID-19 vaccine from AstraZeneca for all age groups, including people older than 65 years
Germany's independent vaccine committee has formally approved giving the AstraZeneca shot to people age 65 and over, the health minister said Thursday
Many state officials and doctors have refused to take Covaxin before its effectiveness could be proved.
Taiwan has signed contracts securing 10 million doses of the AstraZeneca vaccine, 5.05 million doses of the Moderna vaccine and 4.76 million doses of vaccines through COVAX
SII, the world's largest vaccine manufacturer by volume, is mass producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor and middle-income countries
Health Canada's relatively fast approval was underpinned by SII and Verity's four years of working to bring a cancer treatment to Canada
The timeline for the delivery of doses, made by AstraZeneca and by India's Serum Institute, will be split into separate two-month schedules, COVAX said in a statement
Experts say the new analysis adds to growing evidence that the vaccines are working
The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna
Business Standard brings you top news of the evening
The EU and Britain are mainly supplied by local facilities, but production problems have cut deliveries by the British-Swedish drugmaker to the EU, forcing it to look elsewhere
If you are above 45 years old and have one of co-morbidities listed by the govt, you could get a coronavirus vaccine in this phase-2 of vaccination drive. Here's the full list of health issues